ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

ClinicalTrials.gov ID: NCT00046254

Public ClinicalTrials.gov record NCT00046254. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00046254
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
2,127 participants

Conditions and interventions

Interventions

  • Zoledronic Acid Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2002
Primary completion
Jan 31, 2007
Completion
Jan 31, 2007
Last update posted
May 1, 2012

2002 – 2007

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
University of Alabama Hospital Birmingham Alabama 35294
Osteoporosis Diagnostic Center Eureka California 95503
Sharp Grossmont Hosptial La Mesa California 91942
The Permanente Group Santa Rosa California 95403
Radiant Research Lake Worth Lake Worth Florida 33461
Atlanta Resarch Center Decatur Georgia 30033
United Osteoporosis Center Health Services Gainesville Georgia 30501
Galesburg Orthopedic Services LTD Galesburg Illinois 61401
Illinois Bone and Joint Institute Morton Grove Illinois 60053
Mercy Arthritis and Osteoporosis Center Des Moines Iowa 50322
Maine Medical Center Research Institute Portland Maine 04101
University of Maryland School of Medicine Baltimore Maryland 21201
Wayne State University, Div. of Endocrinology Detroit Michigan 48201
Health East Osteoporosis Service Woodbury Minnesota 55125
Highland Hospital Rochester New York 14620
University of North Carolina Hospital Chapel Hill North Carolina 27599
Duke University Health System Durham North Carolina 27710
University Orthopaedics Canfield Ohio 44406
Ohio State University Columbus Ohio 43210
University of Pennsylvania Health System-Presbyterian Medical Center Philadelphia Pennsylvania 19104
Saint Joseph Medical Center West Reading Pennsylvania 19611
Saint Josephs Warwick Rhode Island 02818
Palmetto Richland Memorial Hospital Columbia South Carolina 29203
Seton Medical Center Austin Texas 78705
St. Luke's Episcopal Hospital Houston Texas 77030
Danville Regional Medical Center Danville Virginia 24541
University of Wisconsin Hospital and Clinics Madison Wisconsin 53706

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00046254, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2012 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00046254 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →